Rifaximin

About Granules India

Granules India is a mission-driven pharmaceutical company focused on manufacturing high-quality, affordable essential medicines through a vertically integrated model. Its strategic achievements include establishing a global footprint with 10 manufacturing facilities, securing over 69 ANDA approvals, and serving 300+ customers in 80+ countries. The company's growth strategy is anchored in operational excellence, process innovation, and expanding its portfolio in complex generics and controlled substances to drive sustainable, profitable expansion.

Therapeutic Areas